No Data
Express News | Needham Reiterates Buy on Haemonetics, Maintains $112 Price Target
Haemonetics to Sell Whole Blood Assets to GVS for $67.1 Million
Haemonetics: To Use Proceeds for General Corporate Purposes and Growth Initiatives>HAE
Haemonetics: Transaction Expected to Close in First Quarter of 2025 >HAE
Express News | Haemonetics Corp - Deal Valued at up to $67.1 Million
Express News | Haemonetics Announces Sale of Whole Blood Assets to Gvs, S.p.a